Alto Pharmacy Stock

alto.comHealthcare / Digital HealthFounded: 2015Funding to Date: $656.12MM

Alto Pharmacy is a digital pharmacy focused on delivering prescriptions to patients without delivery fees. As with physical pharmacies, patients are able to chat directly with Alto pharmacists to ask questions about their care across general health, sexual health, heart health, fertility, and more. Alto Pharmacy was founded in 2015 by Jamie Karraker, Mattieu Gamache-Asselin, and Vladimir Blumen and is headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Alto Pharmacy, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Alto Pharmacy’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Alto Pharmacy.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Alicia Davis
Chief Executive Officer
Nihar Bhatt
Chief Financial Officer
Mike McClay
Chief Technology Officer

Board Members

John Westcott
SoftBank Investment Advisers
Neil Shah
Greenoaks Capital Partners
Nichola Eliovits
Olive Tree Capital

Frequently Asked Questions About Alto Pharmacy’s Stock

plusminus
Can you buy Alto Pharmacy’s stock?
Alto Pharmacy is not publicly traded on NYSE or NASDAQ in the U.S. To buy Alto Pharmacy’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Alto Pharmacy’s stock?
Yes, you can sell stock of a private company like Alto Pharmacy. Forge can help you sell your Alto Pharmacy stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Alto Pharmacy’s stock price?
Alto Pharmacy is a privately held company and therefore does not have a public stock price. However, you may access Alto Pharmacy’s private market stock price with Forge Data.
plusminus
What is Alto Pharmacy’s stock ticker symbol?
Alto Pharmacy does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

This Former Auto Executive Is Now CEO of a Billion-Dollar Online Pharmacy
Alicia Boler Davis was the most senior Black executive in the auto industry before joining Amazon, and later, Alto Pharmacy. Her mentors, she says, have pushed her to continually raise the bar for herself.
A Softbank-backed pharmacy startup is working to tackle a $300-billion-a-year prescription drug crisis
For years, the $500 billion prescription drug industry has loomed as an enticing target for disruption-minded entrepreneurs and corporations alike.
On track to hit $1B in revenue this year, Alto Pharmacy tapped an Amazon exec to lead its next phase of growth
Jamie Karraker and Mattieu Gamache-Asselin, who both previously worked at Facebook, bought an independent "mom-and-pop" pharmacy in San Francisco's Mission District to learn the workflows and pain points for consumers, doctors and pharmacists.
Updated on: Feb 28, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.